MCB(MCB)
MCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $381M | $440M | $508M |
| Low | $377M | $435M | $508M |
| High | $384M | $442M | $508M |
| EBITDA Avg | $113M | $130M | $150M |
| Low | $112M | $129M | $150M |
| High | $114M | $131M | $150M |
| EBIT Avg | $110M | $127M | $147M |
| Low | $109M | $126M | $147M |
| High | $111M | $128M | $147M |
| Net Income Avg | $111M | $127M | $159M |
| Low | $110M | $125M | $157M |
| High | $113M | $128M | $160M |
| EPS Avg | $10.40 | $11.84 | $14.80 |
| Low | $10.25 | $11.67 | $14.59 |
| High | $10.48 | $11.94 | $14.92 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $93M | $98M | $101M | $103M | $108M | $113M | $116M |
| Low | $92M | $96M | $100M | $101M | $106M | $111M | $114M |
| High | $95M | $99M | $103M | $104M | $109M | $114M | $118M |
| EBITDA Avg | $28M | $29M | $30M | $30M | $32M | $33M | $34M |
| Low | $27M | $28M | $30M | $30M | $31M | $33M | $34M |
| High | $28M | $29M | $30M | $31M | $32M | $34M | $35M |
| EBIT Avg | $27M | $28M | $29M | $30M | $31M | $33M | $34M |
| Low | $27M | $28M | $29M | $29M | $31M | $32M | $33M |
| High | $27M | $29M | $30M | $30M | $32M | $33M | $34M |
| Net Income Avg | $25M | $27M | $29M | $29M | $31M | $33M | $34M |
| Low | $24M | $27M | $28M | $28M | $30M | $33M | $34M |
| High | $25M | $27M | $29M | $29M | $32M | $34M | $35M |
| EPS Avg | $2.31 | $2.51 | $2.66 | $2.67 | $2.88 | $3.10 | $3.19 |
| Low | $2.26 | $2.49 | $2.61 | $2.61 | $2.82 | $3.03 | $3.13 |
| High | $2.35 | $2.53 | $2.71 | $2.71 | $2.93 | $3.15 | $3.25 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |